The invention generally relates to formulations having particles comprising phospholipids, bioactive agent and excipients and the pulmonary delivery thereof. Dry powder inhaled PTH formulations are disclosed. Improved formulations comprising DPPC, PTH and sodium citrate which are useful in the treatment of lowered PTH conditions are disclosed. Also, the invention relates to a method of for the pulmonary delivery of a bioactive agent comprising administering to the respiratory tract of a patient in need of treatment an effective amount of particles comprising a bioactive agent or any combination thereof in association, wherein release of the agent from the administered particles occurs in a rapid fashion. Kits containing receptacles of the formulations are also disclosed.
本发明一般涉及含有
磷脂、
生物活性剂和赋形剂的颗粒的制剂及其肺部给药。本发明公开了干粉吸入
PTH 制剂。本发明公开了由
DPPC、
PTH 和
柠檬酸钠组成的改进制剂,可用于治疗
PTH 降低的情况。此外,本发明还涉及一种向肺部输送
生物活性剂的方法,该方法包括向需要治疗的患者的呼吸道输送有效量的包含
生物活性剂或其任何组合的颗粒,其中给药颗粒会快速释放药剂。此外,还公开了含有制剂容器的试剂盒。